Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

haseeb-ahmad-abpi-vice-president-4

ABPI names Novartis’ Haseeb Ahmad as new President

May 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Novartis, appointment, pharma

The Association of the British Pharmaceutical Industry (ABPI) has revealed the appointment of a new President: Haseeb Ahmad will assume …
Appointment
robin_washington

Gilead’s CFO and Executive Vice President to depart in 2020

May 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment, pharma

Gilead has announced that Robin Washington, the company’s Senior Vice President and Chief Financial Officer of more than a decade, …
Appointment

Will mobile phones save the NHS?

May 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, UK, feature, mhealth, mobile health, pharma

The NHS is sick. According to politicians and NHS chiefs, the cure involves a strong dose of mHealth. Louis Goss …
Feature
shutterstock_232245868

GSK and Innoviva’s triple asthma therapy Trelegy Ellipta impresses at Phase 3

May 3, 2019 Medical Communications, Research and Development GSK, Innoviva, Trelegy, ellipta, pharma

GSK and partner Innoviva have lifted the curtain on new Phase 3 data for their single inhaler triple therapy Trelegy …
News
haseeb-ahmad-abpi-vice-president-4

ABPI names Novartis’ Haseeb Ahmad as new President

May 3, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Novartis, appointment, pharma

The Association of the British Pharmaceutical Industry (ABPI) has revealed the appointment of a new President: Haseeb Ahmad will assume …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

May 3, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eli Lilly, Gilead, autism, dementia, opioids, pharma

This week was marked by the failure of two Phase 3 trials after both Eli Lilly and Gilead suffered from …
News
allergan

Allergan shareholders reject proposal to split roles of chairman and CEO

May 2, 2019 Research and Development Allergan, Appaloosa, CEO, board of directors, hedge fund, pharma

Allergan shareholders have rejected a proposal to immediately separate the roles of CEO and chairman, both of which are currently …
News

Takeda opens R&D facility in San Diego, California

May 2, 2019 Manufacturing and Production, Research and Development CNS, GI, Japan, Takeda, california, neuroscience, san diego

Japanese-firm Takeda pharmaceuticals has opened a new research facility in San Diego, California. The 165,000ft2 research centre will employ 250 …
News

Hormone-based therapies show promise in children and adults with autism

May 2, 2019 Research and Development ASD, autism, pharma, vasopressin

A hormone-based therapy might improve social function in people with autism, according to the results of two separate clinical trials. …
News
40230318504_a38a3dbfde_z

Ambien and other insomnia meds to be labelled with black box warnings after sleepwalking deaths

May 2, 2019 Medical Communications, Research and Development FDA, ambien, black box warning, insomnia, sleeping pills, warning label

The FDA has said that Ambien, and other insomnia medications, must be labelled with a ‘black box warning’ – the …
News

FDA approves AbbVie’s Mavyret for children with Hepatitis C (HCV)

May 1, 2019 Research and Development AbbVie, HCV, hepatitis C, mavyret, pharma

The FDA has approved AbbVie’s Mavyret tables (glecaprevir/pibrentasvir) as a treatment for hepatitis C (HCV) in children aged 12 to 17 …
News
dw-anzcxqaqavhl

FDA refuses to review Nabriva’s injectable antibiotic for urinary tract infections

May 1, 2019 Research and Development, Sales and Marketing Contepo, Nabriva, pharma, urinary tract infections

Biopharma firm Nabriva Therapeutics has revealed that its antibiotic Contepo (fosfomycin) has been rejected for review by the FDA as …
News
smoking

Diabetes drug may help people quit smoking

May 1, 2019 Research and Development UTHealth, clinical trials, diabetes, smoking smoking cessation

A diabetes drug may help people quit smoking, according to researchers at the University of Texas Health Science Center at …
News
robin_washington

Gilead’s CFO and Executive Vice President to depart in 2020

May 1, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Gilead, appointment, pharma

Gilead has announced that Robin Washington, the company’s Senior Vice President and Chief Financial Officer of more than a decade, …
News
astrocyte5

Scientists identify new form of dementia

May 1, 2019 Research and Development AD, Alzheimer's, dementia, late, neuroscience

A team of scientists from Britain and the United States have described a new form of dementia, according to a …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026